News

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
An elderly couple who hired a contractor to renovate their roof claims they were scammed out of tens of thousands of dollars, ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
Maria Pasqual was a flower farmer in Maili, loved by those who encountered her. The family who lives next door to her farm ...
The suspect told the victim to “shut up,'' sparking a dispute in which she became "aggressive'' and he walloped her multiple ...
There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...
E-bike battery malfunction leads to fire and first NYC battery-related death in 2025, trapping 76-year-old woman in a Queens pizzeria.